We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$35.3M
2
TIF
Tiffany & Co.
TIF
+$27.7M
3
VRNS icon
Varonis Systems
VRNS
+$17.6M
4
OSB
Norbord Inc.
OSB
+$16.7M
5
QEP
QEP RESOURCES, INC.
QEP
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$417M 3.47%
1,953,593
+10
+0% +$2.32K
AAPL icon
2
Apple
AAPL
$4.79T
$410M 3.41%
3,213,399
-17
-0% -$2.18K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.17T
$295M 2.45%
3,500,380
+20
+0% +$1.97K
AMGN icon
4
Amgen
AMGN
$198B
$292M 2.43%
1,324,205
+15
+0% +$3.58K
MRK icon
5
Merck
MRK
$315B
$287M 2.39%
3,832,139
+4
+0% +$295
REGN icon
6
Regeneron Pharmaceuticals
REGN
$68.3B
$187M 1.56%
403,641
+4
+0% +$1.95K
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$120B
$177M 1.47%
779,546
+7
+0% +$1.54K
DHR icon
8
Danaher
DHR
$127B
$170M 1.41%
896,225
-5
-0% -$1.01K
AMZN icon
9
Amazon
AMZN
$2.63T
$168M 1.39%
1,071,520
-20
-0% -$3.17K
TMO icon
10
Thermo Fisher Scientific
TMO
$196B
$164M 1.36%
365,826
-6
-0% -$2.86K
PG icon
11
Procter & Gamble
PG
$347B
$151M 1.26%
1,128,377
-3
-0% -$391
GILD icon
12
Gilead Sciences
GILD
$162B
$123M 1.03%
2,204,936
-4
-0% -$258
PYPL icon
13
PayPal
PYPL
$49B
$121M 1.01%
538,730
-6
-0% -$1.51K
META icon
14
Meta Platforms (Facebook)
META
$1.59T
$119M 0.99%
455,019
+1
+0% +$269
TSM icon
15
TSMC
TSM
$2.18T
$109M 0.9%
1,037,774
-8
-0% -$991
BMY icon
16
Bristol-Myers Squibb
BMY
$124B
$106M 0.89%
1,784,782
-94
-0% -$5.85K
TSLA icon
17
Tesla
TSLA
$1.4T
$106M 0.88%
464,913
– –
QCOM icon
18
Qualcomm
QCOM
$185B
$106M 0.88%
724,579
+1
+0% +$144
BABA icon
19
Alibaba
BABA
$279B
$96M 0.8%
429,666
– –
DIS icon
20
Walt Disney
DIS
$166B
$96M 0.8%
551,499
– –
BIIB icon
21
Biogen
BIIB
$29.2B
$91.9M 0.77%
390,870
– –
ALXN
22
DELISTED
Alexion Pharmaceuticals
ALXN
$91.6M 0.76%
610,282
– –
JNJ icon
23
Johnson & Johnson
JNJ
$615B
$91.3M 0.76%
603,945
-7
-0% -$1.13K
SGEN
24
DELISTED
Seagen Inc. Common Stock
SGEN
$86.2M 0.72%
512,657
+14
+0% +$2.26K
C icon
25
Citigroup
C
$222B
$85.6M 0.71%
1,446,068
-43
-0% -$2.87K
1
2 3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.